Cargando…

Treatment of severe fear of childbirth with haptotherapy: design of a multicenter randomized controlled trial

BACKGROUND: About six percent of pregnant women suffer from severe fear of childbirth. These women are at increased risk of obstetric labour and delivery interventions and pre- and postpartum complications, e.g., preterm delivery, emergency caesarean section, caesarean section at maternal request, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Klabbers, Gert A, Wijma, Klaas, Paarlberg, K Marieke, Emons, Wilco HM, Vingerhoets, Ad JJM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209021/
https://www.ncbi.nlm.nih.gov/pubmed/25293834
http://dx.doi.org/10.1186/1472-6882-14-385
_version_ 1782341205891219456
author Klabbers, Gert A
Wijma, Klaas
Paarlberg, K Marieke
Emons, Wilco HM
Vingerhoets, Ad JJM
author_facet Klabbers, Gert A
Wijma, Klaas
Paarlberg, K Marieke
Emons, Wilco HM
Vingerhoets, Ad JJM
author_sort Klabbers, Gert A
collection PubMed
description BACKGROUND: About six percent of pregnant women suffer from severe fear of childbirth. These women are at increased risk of obstetric labour and delivery interventions and pre- and postpartum complications, e.g., preterm delivery, emergency caesarean section, caesarean section at maternal request, severe postpartum fear of childbirth and trauma anxiety. During the last decade, there is increasing clinical evidence suggesting that haptotherapy might be an effective intervention to reduce fear of childbirth in pregnant women. The present study has been designed to evaluate the effects of such intervention. METHODS/DESIGN: Included are singleton pregnant women with severe fear of childbirth, age ≥ 18 year, randomised into three arms: (1) treatment with haptotherapy, (2) internet psycho-education or (3) care as usual. The main study outcome is fear of childbirth. Measurements are taken at baseline in gestation week 20–24, directly after the intervention is completed in gestation week 36, six weeks postpartum and six months postpartum. Secondary study outcomes are distress, general anxiety, depression, somatization, social support, mother-child bonding, pregnancy and delivery complications, traumatic anxiety symptoms, duration of delivery, birth weight, and care satisfaction. DISCUSSION: The treatment, a standard haptotherapeutical treatment for pregnant women with severe fear of childbirth, implies teaching a combination of skills in eight one hour sessions. The internet group follows an eight-week internet course containing information about pregnancy and childbirth comparable to childbirth classes. The control group has care as usual according to the standards of the Royal Dutch Organisation of Midwives and the Dutch Organization of Obstetrics and Gynaecology. TRIAL REGISTRATION: This trial was entered in the Dutch Trial Register and registered under number NTR3339 on March 4(th), 2012.
format Online
Article
Text
id pubmed-4209021
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42090212014-10-28 Treatment of severe fear of childbirth with haptotherapy: design of a multicenter randomized controlled trial Klabbers, Gert A Wijma, Klaas Paarlberg, K Marieke Emons, Wilco HM Vingerhoets, Ad JJM BMC Complement Altern Med Study Protocol BACKGROUND: About six percent of pregnant women suffer from severe fear of childbirth. These women are at increased risk of obstetric labour and delivery interventions and pre- and postpartum complications, e.g., preterm delivery, emergency caesarean section, caesarean section at maternal request, severe postpartum fear of childbirth and trauma anxiety. During the last decade, there is increasing clinical evidence suggesting that haptotherapy might be an effective intervention to reduce fear of childbirth in pregnant women. The present study has been designed to evaluate the effects of such intervention. METHODS/DESIGN: Included are singleton pregnant women with severe fear of childbirth, age ≥ 18 year, randomised into three arms: (1) treatment with haptotherapy, (2) internet psycho-education or (3) care as usual. The main study outcome is fear of childbirth. Measurements are taken at baseline in gestation week 20–24, directly after the intervention is completed in gestation week 36, six weeks postpartum and six months postpartum. Secondary study outcomes are distress, general anxiety, depression, somatization, social support, mother-child bonding, pregnancy and delivery complications, traumatic anxiety symptoms, duration of delivery, birth weight, and care satisfaction. DISCUSSION: The treatment, a standard haptotherapeutical treatment for pregnant women with severe fear of childbirth, implies teaching a combination of skills in eight one hour sessions. The internet group follows an eight-week internet course containing information about pregnancy and childbirth comparable to childbirth classes. The control group has care as usual according to the standards of the Royal Dutch Organisation of Midwives and the Dutch Organization of Obstetrics and Gynaecology. TRIAL REGISTRATION: This trial was entered in the Dutch Trial Register and registered under number NTR3339 on March 4(th), 2012. BioMed Central 2014-10-08 /pmc/articles/PMC4209021/ /pubmed/25293834 http://dx.doi.org/10.1186/1472-6882-14-385 Text en © Klabbers et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Klabbers, Gert A
Wijma, Klaas
Paarlberg, K Marieke
Emons, Wilco HM
Vingerhoets, Ad JJM
Treatment of severe fear of childbirth with haptotherapy: design of a multicenter randomized controlled trial
title Treatment of severe fear of childbirth with haptotherapy: design of a multicenter randomized controlled trial
title_full Treatment of severe fear of childbirth with haptotherapy: design of a multicenter randomized controlled trial
title_fullStr Treatment of severe fear of childbirth with haptotherapy: design of a multicenter randomized controlled trial
title_full_unstemmed Treatment of severe fear of childbirth with haptotherapy: design of a multicenter randomized controlled trial
title_short Treatment of severe fear of childbirth with haptotherapy: design of a multicenter randomized controlled trial
title_sort treatment of severe fear of childbirth with haptotherapy: design of a multicenter randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209021/
https://www.ncbi.nlm.nih.gov/pubmed/25293834
http://dx.doi.org/10.1186/1472-6882-14-385
work_keys_str_mv AT klabbersgerta treatmentofseverefearofchildbirthwithhaptotherapydesignofamulticenterrandomizedcontrolledtrial
AT wijmaklaas treatmentofseverefearofchildbirthwithhaptotherapydesignofamulticenterrandomizedcontrolledtrial
AT paarlbergkmarieke treatmentofseverefearofchildbirthwithhaptotherapydesignofamulticenterrandomizedcontrolledtrial
AT emonswilcohm treatmentofseverefearofchildbirthwithhaptotherapydesignofamulticenterrandomizedcontrolledtrial
AT vingerhoetsadjjm treatmentofseverefearofchildbirthwithhaptotherapydesignofamulticenterrandomizedcontrolledtrial